[PODCAST] GLP-1 Revolution: Beyond Weight Loss to Healthcare Transformation

	Drug Discovery
	The latest drug discovery news from News Medical

In this episode of Balancing the Future, hosts Chai Nussbaumer and Micah Schweizer unpack the fascinating world of GLP-1 drugs with special guest Ben Locwin, VP at Reliant Life Sciences. Learn the science, historical context, and societal influence behind these revolutionary therapeutics. See how they’re changing medicine and tech landscapes.

Tune in

			Single-dose malaria treatment using four drugs achieves high cure rates in clinical trial Hundreds of malaria patients participating in a Phase 3 clinical trial in Gabon in West Africa were cured via a single dose of a treatment that utilizes four widely available malaria drugs, according to a new study presented today at the Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH).

			Common gout drug shows promise in preventing heart attacks and strokes A widely-used, inexpensive gout drug could reduce heart attacks and strokes in people with cardiovascular disease, according to a new Cochrane review.

	Artificial Intelligence and Acoustofluidics Accelerate Drug Discovery Indiana University researchers are advancing biomedical research with AI-enhanced acoustofluidics, improving drug testing and treatment discovery efficiency.

	Potential breakthrough in treating acute kidney injury with ceramide-targeting drugs Serious damage to short-term kidney function-known as acute kidney injury, or AKI-can be fatal and also increase the risk of irreversible chronic kidney disease. It can be triggered by stressors ranging from sepsis to heart surgery, and it affects more than half of ICU patients.

	Clinical trial confirms ivermectin safety in very young children down to 5 kg Millions of very young children currently excluded from treatment with the drug ivermectin could be safely included in ongoing campaigns against challenging and often neglected tropical diseases such as intestinal worms, scabies and river blindness, according to results from a clinical trial presented today at the Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH).

	Collaborative effort advances next-generation therapies for pancreatic and GI cancers Last year, researchers at the University of California, Riverside, developed a novel "molecular crowbar" strategy to degrade the oncogenic enzyme Pin1, a protein that is overexpressed in many tumors including pancreatic cancer.

	Extended use of anti-clotting drugs reduces risk of recurrent blood clots Extending anti-clotting drugs beyond the initial treatment period of at least 90 days after a first blood clot is linked to lower rates of new clots developing compared with stopping treatment, finds a US study published by The BMJ today.

How would you rate today's newsletter?

Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2025